References
- Koo OM, Rubinstein I and Onyuksel H: ‘Role of nanotechnology in targeted drug delivery and imaging: a concise review’, Nanomedicine, 2005, 1, (3), 193–212.
- Leonetti JP, Machy P, Degols G, Lebleu B and Leserman L: ‘Antibody-targeted liposomes containing oligodeoxyribonucleotides complementary to viral RNA selectively inhibit viral replication.,’ Proc. Natl. Acad. Sci. USA, 1990, 87, (7), 2448–2451.
- Schroeder A, Kost J and Barenholz Y: ‘Ultrasound, liposomes, and drug delivery: principles for using ultrasound to control the release of drugs from liposomes’, Chem. Phys. Lipids, 2009, 162, (1–2), 1–16.
- Schroeder A, Avnir Y, Weisman S, Najajreh Y, Gabizon A, Talmon Y, Kost J and Barenholz Y: ‘Controlling liposomal drug release with low frequency ultrasound: mechanism and feasibility’, Langmuir Acs J. Surf. Colloids, 2007, 23, (7), 4019–4025.
- Demos SM, Onyuksel H, Gilbert J, Sanford R, Kane B, Jungblut P, Pinto J, McPherson DD and Klegerman ME: ‘In vitro targeting of antibody-conjugated echogenic liposomes for site-specific ultrasonic image enhancement’, J. Pharm. Sci., 1997, 86, (2), 167–171.
- Smith D.A.B., Porter T.M. , Martinez J., Huang S., Macdonald R.C., McPherson D.D. and Holland, ‘Destruction threshold of echogenic liposomes with clinical diagnostic ultrasound’, Ultrasound Med. Biol., 2007, 33, (5), 797–809.
- Alkan-Onyuksel H, Demos SM, Lanza GM, Vonesh MJ, Klegerman ME, Kane BJ, Kuszak J and McPherson DD: ‘Development of inherently echogenic liposomes as an ultrasonic contrast agent’, J. Pharm. Sci., 1996, 85, (5), 486–490.
- Kopechek JA, Haworth KJ, Raymond JL, Douglas Mast T, Perrin SR, Klegerman ME, Huang S, Porter TM, McPherson DD and Holland CK: ‘Acoustic characterization of echogenic liposomes: frequency-dependent attenuation and backscatter’, J. Acoust. Soc. Am., 2011, 130, (5), 3472–3481.
- Huang S.-L, Hamilton AJ, Pozharski E, Nagaraj A, Klegerman ME, McPherson DD and MacDonald RC: ‘Physical correlates of the ultrasonic reflectivity of lipid dispersions suitable as diagnostic contrast agents’, Ultrasound Med. Biol., 2002, 28, (3), 339–348.
- Huang S.-L and MacDonald RC: ‘Acoustically active liposomes for drug encapsulation and ultrasound-triggered release’, Biochim. Biophys. Acta, 2004, 1665, (1–2), 134–141.
- Allen C, Dos Santos N, Gallagher R, Chiu GNC, Shu Y, Li WM, Johnstone SA, Janoff AS, Mayer LD, Webb MS and Bally MB: ‘Controlling the physical behavior and biological performance of liposome formulations through use of surface grafted poly(ethylene glycol)’, Biosci. Rep., 2002, 22, (2), 225–250.
- Lin H.-Y and Thomas JL: ‘Factors affecting responsivity of unilamellar liposomes to 20 kHz ultrasound’, Langmuir, 2004, 20, (15), 6100–6106.
- Pong M, Umchid S, Guarino AJ, Lewin PA, Litniewski J, Nowicki A and Wrenn SP: ‘In vitro ultrasound-mediated leakage from phospholipid vesicles’, Ultrasonics, 2006, 45, (1–4), 133–145.
- Tirosh O, Barenholz Y, Katzhendler J and Priev A: ‘Hydration of polyethylene glycol-grafted liposomes’, Biophys. J., 1998, 74, (3), 1371–1379.
- Garbuzenko O, Barenholz Y and Priev A: ‘Effect of grafted PEG on liposome size and on compressibility and packing of lipid bilayer’, Chem. Phys. Lipids, 2005, 135, (2), 117–129.
- Lin H and Thomas JL: ‘PEG-Lipids and oligo (ethylene glycol) surfactants enhance the ultrasonic permeabilizability of liposomes’, 2003, (14), 1098–1105.
- Small EF, Dan NR and Wrenn SP: ‘Low-frequency ultrasound-induced transport across non-raft- forming ternary lipid bilayers,’ Langmuir, 2012, 28, 14364–72.
- Evjen TJ, Nilssen EA, Fowler RA, Røgnvaldsson S, Brandl M and Fossheim SL: ‘Lipid membrane composition influences drug release from dioleoylphosphatidylethanolamine-based liposomes on exposure to ultrasound’, Int. J. Pharm., 2011, 406, (1–2), 114–116.
- Evjen TJ, Hupfeld S, Barnert S, Fossheim S, Schubert R and Brandl M: ‘Physicochemical characterization of liposomes after ultrasound exposure - mechanisms of drug release’, J. Pharm. Biomed. Anal., 2013, 78–79, 118–122.
- Chrzanowski SM, Smith DAB, Kee PH and Holland CK: ‘Ultrasound-mediated release of hydrophilic and lipophilic agents from echogenic liposomes’, J. Ultrasound Med., 2008, 27, (11), 1597–1606.
- Small EF: ‘Ultrasound-induced transport across lipid bilayers: influence of cholestrol, lipid-phase behavior and mechanism of sonoporation’, Drexel University, 2012.
- Veatch SL and Keller SL: ‘Seeing spots: complex phase behavior in simple membranes’, Biochim. Biophys. Acta, 2005, 1746, (3), 172–185.
- Paul S, Russakow D, Nahire R, Nandy T, Ambre AH, Katti K, Mallik S and Sarkar K: ‘In vitro measurement of attenuation and nonlinear scattering from echogenic liposomes’, Ultrasonics, 2012, 52, (7), 962–969.
- Huang S.-L, McPherson DD and Macdonald RC: ‘A method to co-encapsulate gas and drugs in liposomes for ultrasound-controlled drug delivery’, Ultrasound Med. Biol., 2008, 34, (8), 1272–1280.
- Small EF, Willy MC, Lewin PA and Wrenn SP: ‘Ultrasound-induced transport across lipid bilayers: Influence of phase behavior’, Colloids Surf. A Physicochem. Eng. Asp., 2011, 390, (1–3), 40–47.
- Gregor Cevc AP, Blume G, Schätzlein A and Gebauer D: ‘Phospholipids handbook’, 427–432; 1993, New York, Marcel Dekker.
- Iglic A: ‘Advances in planar lipid bilayers and liposomes’, 2011, 98–99.
- Needham D, Anyarambhatla G, Kong G and Al E: ‘A new temperature-sensitive liposome for use with mild hyperthermia: characterization and testing in a human tumor xenograft model’, Cancer Res., 2000, 60, 1197–1201.
- Schroeder J, Honen A, Brandl R, Gabizon M, Barenholz A and Kost Y: ‘Ultrasound: an effective tool for controlling the release of drugs from PEGylated liposomes’, CRS, 2008.